Trans-lymphatic contrast-enhanced ultrasound with sentinel lymph node biopsy for detecting cervical skip metastasis to lymph nodes in early-stage oral tongue squamous cell carcinoma

• Published in: Dento-maxillo-facial radiology Vol. 51; no. 2; p. 20210107
• Main Authors: Huang, Jian, Wu, Song-song, Zheng, Song, Gao, Hong, Wu, Zhi-yuan, Xu, Jun-wu
• Format: Journal Article
• Language: English
• Published: England The British Institute of Radiology 01.02.2022
• Subjects: Carcinoma, Squamous Cell - diagnostic imaging; Contrast Media; Head and Neck Neoplasms; Humans; Lymph Nodes - diagnostic imaging; Sentinel Lymph Node - diagnostic imaging; Sentinel Lymph Node Biopsy; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms - diagnostic imaging; sentinel lymph node; skip metastasis; contrast-enhanced ultrasound; tongue; squamous cell carcinoma
• ISSN: 0250-832X; 1476-542X
• DOI: 10.1259/dmfr.20210107

The purpose of this study was to assess whether trans-lymphatic contrast-enhanced ultrasound (CEUS) combined with sentinel lymph node biopsy can be used to assess the status of cervical lymph nodes and skip metastasis in patients with early squamous cell carcinoma (SCC) of the oral tongue. This study included 21 subjects with early oral tongue SCC who received multiple intramucosal peritumoral injections of Sonazoid. CEUS examinations were performed immediately after Sonazoid injection to identify sentinel lymph nodes (SLNs). The SLNs were excised for histological examination to determine if the lymph nodes has metastases. Thirty-five SLNs were detected by CEUS after Sonazoid injection in the subjects. SLNs were identified in 20 of the total 21 subjects. Four participants had metastasis to lymph nodes, and one had skip metastasis in level Ⅲ. In one subject, SLNs were successfully detected in level Ⅳ without skip metastasis. Trans-lymphatic CEUS combined with sentinel lymph node biopsy showed high accuracy for evaluating cervical lymph node status. This could be a reliable approach for detecting cervical skip metastases of lymph nodes in early-stage oral cancer patients.